Dosing

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Senseonics and Sequel Med Tech have launched a Type 1 …

Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, intended for treating type 2 diabetes …

This transcript has been edited for clarity. The U.S. Food and Drug Administration's Endocrine Advisory Committee voted against recommending approval of once-weekly insulin Icodec to treat people with diabetes. Type …

Zepbound is a new drug used for weight loss and maintenance in people who are overweight or obese.it was Approved by the US Food and Drug Administration (FDA) 2023. It …